Revenue | $100 - $500 million See Exact Annual Revenue |
---|---|
Employees | 500 - 1,000Exact Company Size |
Primary Industry | 5417 Scientific Research & Development Services |
Address | 3535 General Atomics Ct Suite 200 San Diego, CA 92121 |
Fate Therapeutics | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | $100 - $500 million Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): |
Fate Therapeutics P&L | $ Millions |
---|---|
Revenue (Sales) | |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
NKAR pharmaceutical preparations for the treatment of cancer; therapeutic agents for the treatment of cancer; cells and cell-derived preparations for medical, clinical, and therapeutic use; cells and cell-derived preparations for clinical, medicinal, and therapeutic purposes; biological preparations for therapeutic purposes; biological preparations for a therapeutic material, namely, cell lines used for medical cell therapy; pharmaceutical preparations and substances for the treatment of immunological diseases and cancer | 04/02/2019 |
TFINITY Cells for medical use; therapeutic cell preparation for the treatment of cancer, infectious diseases, and immune disorders; therapeutic agents for the modulation of cells for use as immunotherapies; pharmaceutical preparations for the treatment of cancer, infectious diseases, and immune disorders; kits comprised of cells and pharmaceutical preparations for the treatment of cancer, infectious diseases, and immune disorders for medical or clinical use; bio-engineered component for a therapeutic material, namely, cell lines for medical or clinical use used for immunotherapy | 08/18/2016 |
TOLERACYTE stem cells for medical purposes; therapeutic cell preparation for the treatment of auto-immune diseases, and inflammatory and immune disorders; therapeutic agents for the modulation of cells for use as immunotherapies | 06/06/2016 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
LEIDOS | Denver, CO | 100 |
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 30 |
INC RESEARCH | Raleigh, NC | 27 |
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
SYNEOS HEALTH | Raleigh, NC | 13 |
ILLUMINA | San Diego, CA | 12 |
UT-BATTELLE | Oak Ridge, TN | 11 |
PRA HOLDINGS | Raleigh, NC | 11 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
ILLUMINA | San Diego, CA | 100 |
NEUROCRINE BIOSCIENCES | San Diego, CA | 23 |
SANTARUS | San Diego, CA | 16 |
HALOZYME THERAPEUTICS | San Diego, CA | 15 |
MIRATI THERAPEUTICS | San Diego, CA | 12 |
FATE THERAPEUTICS | San Diego, CA | 11 |
Company | Revenue ($ MM) |
---|---|
|